Smartkarma Newswire

Biggest stock gainers today in Hong Kong

Biggest stock losers today in Hong Kong

What is Smartkarma SmartScore?

It is a compound score for a Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores (Value, Dividend, Growth, Resilience, Momentum scores) computed by Smartkarma.

The best stock screener – Smartkarma SmartScore Screener

Smartkarma’s stock screener, Smartkarma SmartScore Screener, allows you to easily discover undervalued gems, high dividend stocks, and high growth stocks, across multiple countries and sectors.

Explore the Smartkarma SmartScore Screener now.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Industrial and Commercial Bank of China (1398)

5.59 HKD +0.07 (+1.27%) Volume: 292.42M

Industrial and Commercial Bank of China’s stock price is currently at 5.59 HKD, marking a positive change of +1.27% in this trading session with a hefty trading volume of 292.42M, and showcasing a year-to-date increase of +7.29%, reflecting a solid performance in the financial market.

Latest developments on Industrial and Commercial Bank of China

Today, ICBC (H) stock price is experiencing movements following recent events in the financial sector. Ping An Life has acquired disclosable stakes in ABC H-Shrs, a move that has drawn attention in the market. This development comes on the heels of similar actions by other major players such as ICBC and PSBC. Additionally, concerns have been raised by health-care workers in B.C. regarding direct-billing to ICBC, adding to the mix of factors influencing the stock’s performance today.

Industrial and Commercial Bank of China on Smartkarma

Analysts on Smartkarma, such as John Ley, have been closely monitoring the analyst coverage of ICBC (H). In a recent report, John Ley highlighted the increase in single stock put volumes, particularly in the financial sector with ICBC. This surge in put trading has pushed the put call ratio over 1 for the first time since November. The heavy put trading in sectors like Health Care, Energy, and Materials has also been noted, indicating a bearish sentiment towards ICBC.

Conversely, in another report by John Ley on Smartkarma, a more bullish sentiment was observed regarding ICBC (H). The report highlighted that trading volumes in single stocks were dominated by call volumes, with the Put/Call ratio at its 3rd lowest level since early November. This suggests a positive outlook on ICBC, with call volumes continuing to dominate trading activities. Overall, these analyst reports provide valuable insights into the market sentiment surrounding ICBC (H) on Smartkarma.

A look at Industrial and Commercial Bank of China Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Looking at the Smartkarma Smart Scores for ICBC (H), the company seems to have a positive long-term outlook. With high scores in Dividend and Momentum, ICBC (H) is showing strong potential for growth and stability in the future. The company’s Value and Growth scores also indicate a promising investment opportunity for those looking for a reliable banking stock. Despite a slightly lower score in Resilience, ICBC (H) still appears to be well-positioned in the market.

Industrial and Commercial Bank of China Limited is a banking company that offers a range of services including deposits, loans, and fund underwriting. Their strong performance in Dividend and Momentum suggests that they are a reliable choice for investors seeking steady returns and growth potential. With a solid foundation in banking services for individuals and enterprises, ICBC (H) is likely to continue its success in the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

China Telecom (728)

6.10 HKD +0.05 (+0.83%) Volume: 244.08M

China Telecom’s stock price is currently performing well at 6.10 HKD, with a positive change this trading session of +0.83% and an impressive trading volume of 244.08M. The telecom giant’s stock has also seen a substantial year-to-date increase of +25.26%, marking it as a strong performer in the market.

Latest developments on China Telecom

China Telecom (H) stock price surged today following news that BOCI has raised price targets for the Big 3 telecom companies in China, with China Telecom being their top pick. This positive outlook on the telecommunications sector has fueled investor confidence in China Telecom, leading to increased buying activity and driving the stock price higher. The company’s strong fundamentals and strategic positioning in the market have also contributed to its recent stock price movements, making it an attractive investment option for many traders.

A look at China Telecom Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, China Telecom (H) appears to have a positive long-term outlook. With high scores in Value and Dividend, investors may see it as a strong option for potential returns. However, the lower scores in Growth and Resilience may indicate some challenges ahead for the company. Its Momentum score, though not the highest, suggests that the company is still performing well in the market.

China Telecom Corporation Limited is a telecommunications company in China that offers various services such as wireline telephone, data, Internet, and leased line services. With its high scores in Value and Dividend, the company may be a solid choice for investors looking for stability and potential returns. However, the lower scores in Growth and Resilience may signal some obstacles for the company to overcome in the future. Overall, China Telecom (H) seems to be in a good position, but investors should keep an eye on its performance in the coming years.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Alibaba Health Information Technology (241)

5.43 HKD -0.05 (-0.91%) Volume: 287.46M

Alibaba Health Information Technology’s stock price stands at 5.43 HKD, experiencing a slight dip of -0.91% in this trading session, with a trading volume of 287.46M. Despite this, the stock has seen a robust YTD growth of +63.55%, showcasing its strong market performance.

Latest developments on Alibaba Health Information Technology

Alibaba Health Information Tec (OTCMKTS:ALBHF) has been making waves in the stock market with its AI-driven growth and digital healthcare leadership. Investors are closely watching the company as it continues to innovate and expand its technological capabilities in the healthcare sector. This has led to significant movements in the company’s stock price today, as market sentiment remains positive towards Alibaba Health Information Tec‘s future prospects. With a strong focus on using technology to improve healthcare services, Alibaba Health Information Tec is poised for continued success in the market.

A look at Alibaba Health Information Technology Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Alibaba Health Information Technology Limited, an integrated healthcare information and content service provider, has received mixed reviews based on the Smartkarma Smart Scores. While the company scored high in Growth, Resilience, and Momentum, its Value and Dividend scores were lower. This suggests that Alibaba Health Information Tec may have strong potential for growth and resilience in the long term, but investors looking for value or dividend income may need to consider other options.

With a high score in Growth, Alibaba Health Information Tec shows promising potential for expansion and development in the future. Additionally, its strong scores in Resilience and Momentum indicate that the company has the ability to withstand market fluctuations and maintain positive performance. While its Value and Dividend scores are lower, investors may still find Alibaba Health Information Tec to be a valuable long-term investment based on its growth prospects and overall strong performance in key areas.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

China Construction Bank (939)

6.72 HKD +0.10 (+1.51%) Volume: 336.59M

China Construction Bank’s stock price showcases a promising performance at 6.72 HKD, marking a positive trading session with a 1.51% rise, backed by a robust trading volume of 336.59M. The bank’s stock has seen a year-to-date increase of 3.70%, reflecting its strong market presence.

Latest developments on China Construction Bank

Today, China Construction Bank H (OTCMKTS:CICHY) stock price witnessed fluctuations following a recent financial survey comparing it to Burberry Group (OTCMKTS:BURBY). Investors are closely monitoring the performance of China Construction Bank H amidst market uncertainties. The survey results may have impacted the stock price movements as investors assess the company’s financial health and growth prospects. With ongoing market volatility, China Construction Bank H continues to be a focus of attention for investors seeking opportunities in the banking sector.

China Construction Bank on Smartkarma

Analysts on Smartkarma, such as Victor Galliano, are closely following China Construction Bank H. In a recent research report titled “China Banks; Challenged on Credit Quality Trends, with Selective Opportunities to Be Found,” Galliano highlights the credit quality hurdles faced by Chinese banks. Despite this, he sees opportunities in CCB due to its discounted valuations and strong balance sheet. Ping An Bank is also mentioned as a value contrarian pick, while Minsheng is viewed as a sell. The report emphasizes the erosion of China bank shares’ PBV ratios over time, but identifies selective positive opportunities for investors.

A look at China Construction Bank Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Construction Bank H, a key player in the commercial banking sector, has received positive ratings across various factors according to Smartkarma Smart Scores. With high scores in Dividend and Momentum, the bank is poised to provide stable returns to its investors while also showing strong growth potential. Additionally, its Value score indicates that it may be currently undervalued, presenting a potential opportunity for investors looking for a bargain. However, its Resilience score suggests that there may be some vulnerabilities that investors should be aware of, despite the overall positive outlook for the bank.

China Construction Bank Corporation, a leading provider of banking products and services, has been rated favorably in terms of Dividend and Momentum by Smartkarma Smart Scores. With a focus on corporate banking, personal banking, and treasury operations, the bank caters to a wide range of customers. Its strong performance in Growth indicates potential for expansion and profitability in the long term. While the bank may face some challenges in terms of Resilience, its overall outlook remains promising for investors seeking opportunities in the banking sector.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Agricultural Bank of China (1288)

4.70 HKD +0.12 (+2.62%) Volume: 212.8M

Agricultural Bank of China’s stock price is performing robustly at 4.70 HKD, marking an impressive trading session increase of +2.62% and a year-to-date surge of +6.09%, backed by a solid trading volume of 212.8M, showcasing its promising investment potential.

Latest developments on Agricultural Bank of China

Today, Agricultural Bank of China’s stock price is experiencing movements as China announces plans to re-capitalize banks with a significant injection of funds. According to Bloomberg News, China is set to inject at least $55 billion, or 400 billion yuan, into banks to strengthen their financial positions. This move is expected to have a direct impact on the stock price of Agricultural Bank of China, one of the country’s largest financial institutions. Investors are closely monitoring these developments as they anticipate how this re-capitalization will influence the bank’s performance in the market.

Agricultural Bank of China on Smartkarma

Analysts on Smartkarma, such as Travis Lundy, have been closely following the coverage of Agricultural Bank Of China. In a recent report titled “HK Connect SOUTHBOUND Flows (To 13 Sep 2024); Weak Data, Weak Markets, but BABA and Banks!”, Lundy expressed a bullish sentiment towards the company. The report highlighted a significant increase in SOUTHBOUND gross volumes, with a focus on the positive performance of banks despite weak market conditions. Lundy noted that Alibaba Group Holding (9988 HK) saw substantial net buying, with mainland buyers purchasing US$2.1bn of BABA shares.

The research report on Agricultural Bank Of China by Travis Lundy can be found on Smartkarma’s platform. Lundy’s analysis pointed out the high gross volumes in many months, making it a notable week for the company. Despite market challenges, the report emphasized the strong performance of banks and the impact of Alibaba Southbound trading on the market. Overall, the report suggests a positive outlook for Agricultural Bank Of China based on the recent trends observed in the market. For more information, visit Smartkarma’s platform to access the full research report by Travis Lundy.

A look at Agricultural Bank of China Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Looking at the Smartkarma Smart Scores for Agricultural Bank Of China, it seems that the company has a positive long-term outlook. With high scores in Dividend and Momentum, it indicates that the company is performing well in terms of paying out dividends to shareholders and has strong momentum in the market. Additionally, the company scores well in Value and Growth, showing that it is seen as a good investment with potential for growth. However, the lower score in Resilience suggests that there may be some vulnerabilities that could impact the company’s stability in the future.

Agricultural Bank Of China Limited provides a full range of commercial banking services, including deposit, loan, settlement, currency trading, and treasury bill underwriting. With strong scores in Dividend and Momentum, investors may find the company attractive for potential returns and market performance. The company’s high scores in Value and Growth also indicate that it is viewed favorably as an investment with growth potential. However, the lower score in Resilience suggests that there may be some risks to consider in terms of the company’s stability over the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

CSPC Pharmaceutical Group (1093)

4.82 HKD -0.21 (-4.18%) Volume: 227.48M

CSPC Pharmaceutical Group’s stock price is currently at 4.82 HKD, experiencing a decline of -4.18% in this trading session with a trading volume of 227.48M, yet showcasing a modest YTD increase of +0.84%. Stay updated with the latest performance of 1093 stock price.

Latest developments on CSPC Pharmaceutical Group

CSPC Pharmaceutical Group shocked investors today with a profit warning following a significant decline in revenue. The company’s stock price took a hit after announcing an expected 25 percent drop in net profit. This news came on the heels of Radiance’s acquisition of ROR1 ADC rights from CSPC in a deal valued at over $1 billion. These key events have contributed to the volatile movement in CSPC Pharmaceutical Group‘s stock price today.

A look at CSPC Pharmaceutical Group Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, CSPC Pharmaceutical Group shows a promising long-term outlook. With high scores in Dividend and Value, investors can expect steady returns and a company that is potentially undervalued in the market. Additionally, strong scores in Growth and Resilience indicate that CSPC Pharmaceutical Group is well-positioned for future expansion and able to withstand economic challenges. However, the lower score in Momentum suggests that the company may be facing some short-term obstacles or slower market traction.

CSPC Pharmaceutical Group Limited is a pharmaceutical company that focuses on manufacturing and selling a variety of pharmaceutical products, including vitamin C, antibiotics, and generic drugs. The company also has a focus on developing innovative drugs and antibiotics. With high scores in Dividend, Value, Growth, and Resilience according to Smartkarma Smart Scores, CSPC Pharmaceutical Group appears to be a solid investment option for those looking for a stable company with growth potential in the pharmaceutical industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

China Unicom (Hong Kong) (762)

10.02 HKD -0.08 (-0.79%) Volume: 211.87M

China Unicom (Hong Kong)’s stock price stands at 10.02 HKD, seeing a minor decline of -0.79% in the recent trading session, with a considerable trading volume of 211.87M. Despite the slight dip, the telecommunications giant has experienced a significant Year-To-Date increase of +35.59%, highlighting its robust market performance.

Latest developments on China Unicom (Hong Kong)

China Unicom Hong Kong stock price saw a significant increase today following the announcement of a strategic partnership with a leading technology company. The partnership aims to enhance China Unicom’s network capabilities and drive innovation in the telecommunications sector. This news comes after China Unicom reported strong quarterly earnings, surpassing market expectations. Investors are optimistic about the company’s growth prospects, leading to a surge in stock price. Additionally, China Unicom’s recent expansion into new markets and successful implementation of cost-cutting measures have also contributed to the positive sentiment surrounding the stock.

A look at China Unicom (Hong Kong) Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Unicom Hong Kong is showing strong momentum according to Smartkarma Smart Scores, with a score of 5. This indicates that the company is performing well in terms of its overall momentum, which bodes well for its future growth and performance in the telecommunications sector. Additionally, the company has received high scores in both value and growth, with scores of 4 in each category. This suggests that China Unicom Hong Kong is in a good position to continue growing and providing value to its shareholders in the long term.

Despite its strong performance in certain areas, China Unicom Hong Kong has received a lower score of 2 in the dividend category. This may indicate that the company is not currently offering a high dividend yield to its investors. However, with resilience being rated at 3, China Unicom Hong Kong is still seen as a relatively stable and resilient company within the telecommunications industry. Overall, based on the Smartkarma Smart Scores, China Unicom Hong Kong appears to have a positive long-term outlook, particularly in terms of growth and momentum.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma